pharmaceutical

The Medical Science Liaison Society’s Samuel Dyer—The Thought Leader Select Interview, Part Two

Thought Leader Select is a company focused on driving industry collaborations among biopharmaceutical, medical device, and diagnostics companies with leading medical experts and centers of excellence, with the ultimate goals of these collaborations being two-fold in purpose:  better treatment options for patients and better outcomes for global public health.  As part of our company’s mission, …

The Medical Science Liaison Society’s Samuel Dyer—The Thought Leader Select Interview, Part Two Read More »

Clinical Trial Ethics

Industry Insights from Paul Meade, M. Sc, MPH According to an article published in the Archives of Internal Medicine, Dr Joseph Ross claimed a study conducted by Parke-Davis, before it was acquired by Pfizer, using gabapentin (Neurontin), as the drug under investigation, appeared to be a “seeding” trial. And while the author states that seeding …

Clinical Trial Ethics Read More »